Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 232,183 |
|
|||||
| News | - | ||||||
| Day High | 2.24 | Low High |
|||||
| Day Low | 2.18 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Seer Inc | SEER | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.08 | 3.70% | 2.24 | 15:00:10 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.20 | 2.18 | 2.24 | 2.24 | 2.16 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,749 | 232,183 | US$ 2.20 | US$ 511,596 | - | 1.455 - 5.65 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:08:22 | 50 | US$ 2.24 | USD |
Seer Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 145.09M | 64.77M | - | 16.66M | -86.28M | -1.33 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Seer News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SEER Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.80 | 2.24 | 1.78 | 2.01 | 568,772 | 0.44 | 24.44% |
| 1 Month | 1.74 | 2.24 | 1.61 | 1.83 | 561,026 | 0.50 | 28.74% |
| 3 Months | 1.79 | 2.24 | 1.51 | 1.84 | 539,360 | 0.45 | 25.14% |
| 6 Months | 1.70 | 2.24 | 1.455 | 1.78 | 485,743 | 0.54 | 31.76% |
| 1 Year | 3.29 | 5.65 | 1.455 | 2.32 | 382,732 | -1.05 | -31.91% |
| 3 Years | 51.09 | 51.49 | 1.455 | 13.29 | 410,219 | -48.85 | -95.62% |
| 5 Years | 48.00 | 86.55 | 1.455 | 19.20 | 417,262 | -45.76 | -95.33% |
Seer Description
| Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome. |
